Clidinium bromide

Base Information

• Chemical Name: Clidinium bromide
• CAS No.: 3485-62-9
• Molecular Formula: C22H26NO3^.Br
• Molecular Weight: 432.357
• Hs Code.: 2933399090
• European Community (EC) Number: 222-471-3
• NSC Number: 756686
• UNII: 91ZQW5JF1Z
• DSSTox Substance ID: DTXSID7022835
• Wikipedia: Clidinium_bromide
• Wikidata: Q27106183
• NCI Thesaurus Code: C65336
• RXCUI: 48212
• ChEMBL ID: CHEMBL1200950
• Mol file: 3485-62-9.mol

Synonyms:clidinium;clidinium bromide;clidinium iodide;clidinium iodide, (+-)-isomer;clidinium iodide, 11C-labeled;clidinium iodide, 3H-labeled;clidinium, 1-(methyl-11C)-labeled;clidinium, 11C-labeled;clidinium, 3H-labeled;N-methyl quinuclidinyl benzilate

Chemical Property of Clidinium bromide

Chemical Property:

• Appearance/Colour: White crystalline solid
• Melting Point: 240-241 °C
• PSA: 46.53000
• LogP: -0.33270
• Storage Temp.: Refrigerator
• Solubility.: DMSO (Slightly), Methanol (Slightly, Sonicated), Water (Slightly)
• Hydrogen Bond Donor Count: 1
• Hydrogen Bond Acceptor Count: 4
• Rotatable Bond Count: 5
• Exact Mass: 431.10961
• Heavy Atom Count: 27
• Complexity: 482

Purity/Quality:

98%,99%, ^*data from raw suppliers

Clidinium bromide ^*data from reagent suppliers

Safty Information:

• Pictogram(s): Xn
• Hazard Codes: Xn
• Statements: 22
• Safety Statements: 36

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O.[Br-]
• Description: Clidinium is a gastrointestinal muscarinic receptor antagonist (Ki = 3 nM against [3H]quinuclidinyl benzilate binding in rat colonic enterocytes). Administration of clidinium, at a dose of 1 mg/kg, slows intestinal transit and induces constipation in mice. This clidinium-induced constipation induces serum hyperammonemia and decreases clonic, myoclonic, and tonic seizure thresholds in a murine pentylenetetrazole-induced epilepsy model.
• Uses: An anticholinergic. Used as an antispasmodic An anticholinergic. Used as an antispasmodic.
• Therapeutic Function: Anticholinergic, Antiulcer
• Clinical Use: This anticholinergic agent is marketed alone and in combinationwith the minor tranquilizer chlordiazepoxide (Librium)in a product known as Librax. The rationale of the combinationfor the treatment of GI complaints is the use of an anxiety-reducing agent together with an anticholinergic agent,based on the recognized contribution of anxiety to the developmentof the diseased condition. It is suggested for pepticulcer, hyperchlorhydria, ulcerative or spastic colon, anxietystates with GI manifestations, nervous stomach, irritable orspastic colon, and others. Clidinium bromide is contraindicatedin glaucoma and other conditions that may be aggravatedby the parasympatholytic action, such as prostatic hypertrophyin elderly men, which could lead to urinary retention.

Technology Process of Clidinium bromide

There total 1 articles about Clidinium bromide which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield:

methyl bromide (74-83-9) → clidinium bromide (3485-62-9)

Guidance literature:

With chloroform; acetone;

DOI:10.1021/ja01119a534

Reference yield:

bromothymol blue (76-59-5) + clidinium bromide (3485-62-9) → Br(1-)*C22H26NO3(1+)*C27H28Br2O5S

Guidance literature:

pH=3; aq. buffer;

Reference yield:

clidinium bromide (3485-62-9) + 3',3'',5',5''-tetrabromophenolsulphonephthalein sodium salt (62625-28-9) → clidinium-BPB complex

Guidance literature:

pH=3; aq. buffer;

upstream raw materials:

methyl bromide